Document is current
Any future updates will be listed below
-
Authors
Kraehenbuehl, L.
Kang, D.
Bang, A. S.
Ketosugbo, K. F.
Hay, J.
Patil, Sujata
Goldfarb, S.
Cho, J.
Lacouture, M. E.
-
Funding
Funding for this research was provided by:
RJR fund
NIH/NCI Cancer Center Support Gran (P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748)
Swiss National Science Foundation (P400PM_199318)
University of Zurich
- License Information
-
More Information
Article History
Received: 6 November 2023
Accepted: 10 May 2024
First Online: 22 May 2024
Declarations
:
: LK, DK, KFK, ASB, JH, SG and JC declare no conflict of interest; SP is a consultant for ByHeart, MEL: has a consultant role with Johnson and Johnson, Novocure, QED, Bicara, Janssen, Novartis, F. Hoffmann-La Roche AG, EMD Serono, Astrazeneca, Innovaderm, Deciphera, DFB, Azitra, Kintara, RBC/La Roche Posay, Trifecta, Varsona, Genentech, Loxo, Seattle Genetics, Lutris, OnQuality, Azitra, Roche, Oncoderm, NCODA, Apricity. MEL also receives research funding from Lutris, Paxman, Novocure, J&J, US Biotest, OQL, Novartis, and AZ
